CORC

在结果中检索

CORC

浏览/检索结果: 共166条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Phase Compensation Method for Active Phased Array Antennas in Operating Environment based on Electromechanical Coupling Model 会议论文
Rome, Italy, 29 August - 5 September 2020
作者:  Wang, Yan;  Wang, Congsi;  Yan, Yuefei;  Tian, Jun;  Liu, Jing
收藏  |  浏览/下载：18/0  |  提交时间：2021/07/02
A Structure and Circuit Coupling Modeling Method for Flexible Interconnection Points and Transmission Performance of Gold Belt in Microwave Modules 会议论文
Hong Kong, China, August 12, 2019 - August 15, 2019
作者:  Tian, Jun;  Wang, Congsi;  Liu, Shaoyi;  Zhu, Cheng;  Zhou, Cheng
收藏  |  浏览/下载：20/0  |  提交时间：2021/07/06
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
Total-Body Parametric Imaging using Kernel and Direct Reconstruction on the uEXPLORER 会议论文
作者:  Zhang, Xuezhu;  Xie, Zhaoheng;  Berg, Eric;  Judenhofer, Martin;  Liu, Weiping
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
Offering artificial intelligence development situation analysis service for users 会议论文
16th International Conference on Service-Oriented Computing, ICSOC 2018, Hangzhou, China, 2018-11-12
作者:  Xu, Xiujuan;  Jiang, Tingting;  Shan, Shimin;  Ni, Jun;  Wang, Kai
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan
收藏  |  浏览/下载：30/0  |  提交时间：2019/12/05
Action recognition using visual attention with reinforcement learning 会议论文
作者:  Li, Hongyang;  Chen, Jun;  Hu, Ruimin;  Yu, Mei;  Chen, Huafeng
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace